Skip to main content
Equibles

Keith A. Goldan

Board Member

Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics Inc. (ABEO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Abeona Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get ABEO alerts

About Keith A. Goldan

Keith A. Goldan is recorded as Board Member at Abeona Therapeutics Inc. (ABEO). The newest filing on record that lists Keith A. Goldan as Board Member at Abeona Therapeutics Inc. (ABEO) is dated April 27, 2026. Abeona Therapeutics Inc. reported in an 8-K filed April 7, 2026 that Keith A. Goldan was appointed Chair of the Audit Committee, effective April 1, 2026. Abeona Therapeutics Inc. reported in an 8-K filed April 7, 2026 that Keith A. Goldan was appointed member of the Board of the Company as a Class 1 director, effective April 1, 2026. Abeona Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Abeona Therapeutics Inc. includes Michael Amoroso (CEO, Chairman, COO and Board Member), Vishwas Seshadri (CEO and Board Member), Brian J.G. Pereira (Chairman and Board Member) and 7 others.

“The Board also appointed Mr. Goldan to serve as Chair of the Audit Committee.”
Abeona Therapeutics Inc. Form 8-K, filed April 7, 2026 · Read the filing
“On April 1, 2026, the Board of Directors (the "Board") of Abeona Therapeutics Inc. (the "Company"), acting upon the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Board from nine to ten members and appointed Keith A. Goldan as a member of the Board of the Company as a Class 1 director.”
Abeona Therapeutics Inc. Form 8-K, filed April 7, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Abeona Therapeutics Inc.

Recent activity